GlaxoSmithKline Investors

GlaxoSmithKline develops and markets products in the areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.

Investors

Industry: Biotechnology, Health Care, Pharmaceutical
Headquarters: London, England, United Kingdom
Founded Date: 1967
Employees Number: 10001+
Funding Status: IPO
Number Of Exits: 12
Acquisitions Number: 22
Investors Number: 1
Total Funding: 25510000
Estimated Revenue: $10B+
Last Funding Date: 2021-03-02
Last Funding Type: Grant

Visit Website
Simon.M.Bicknell@gsk.com
http://twitter.com/gsk
Register and Claim Ownership